Skip to main content
SpringerLink
Log in

Reduction of Peptic Ulcer Disease and Helicobacter pylori Infection but Increase of Reflux Esophagitis in Western Sydney Between 1990 and 1998

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We aimed to determine if changes in the patterns of upper gastrointestinal diseases at endoscopy have occurred over the past decade. Retrospectively, 917 consecutive patients were selected based on upper endoscopy between June 1 and August 31, in 1990 (n = 217), 1994 (n = 270), and 1998 (n = 430). Demographic, clinical, endoscopic, and histological information were extracted from the medical records on a standardized case record form. Over the eight-year period, follow-up of peptic ulcer (15%, 5%, and 5%, respectively, in 1990, 1994, and 1998, df = 2, P < 0.001), bleeding (22%, 14%, and 13%, P = 0.008), and nausea/vomiting (15%, 16%, and 10%, df = 2, P = 0.003) had become less frequent, but reflux (21%, 19%, and 34%, df = 2, P < 0.001) and dyspepsia (24%, 43%, and 32%, df = 2, P < 0.001) more frequent indications for upper endoscopy. The prevalence of peptic ulcer disease decreased (22%, 15%, and 13%, df = 2, P = 0.025), but the prevalence of reflux esophagitis increased significantly (29%, 30%, and 39%, df = 2, P = 0.010). The prevalence of both the use of nonsteroidal antiinflammatory drugs (NSAIDs) (18%, 20%, and 11%, respectively, in 1990, 1994, and 1998, df = 2, P = 0.004) and H. pylori infection (39% in 1994 and 30% in 1998, df = 1, P = 0.032) decreased. Overall, NSAID use was independently associated with gastric ulcers (OR = 2.39, 95% CI 1.21–4.73, χ2 = 6.31, df = 1, P = 0.012), but not esophagitis. H. pylori infection was independently associated with duodenal ulcers (OR = 4.74, 95% CI 2.30–9.77, χ2 = 17.8, df = 1, P < 0.001), histologically chronic (OR = 166.8, 95% CI 76.1–365.4, χ2 = 313.0, df = 1, P < 0.001) and active (OR = 30.1, 95% CI 17.0–53.5, χ2 = 189.7, df = 1, P < 0.001) gastritis and lymphoid aggregates (OR = 5.49, 95% CI 3.02–9.97, χ2 = 36.3, df = 1, P < 0.001). In conclusion, the prevalence of peptic ulcer disease appears to have been decreasing, whereas reflux esophagitis has been increasing over the past decade in Western Sydney. The decreased use of NSAIDs and decline of H. pylori infection have likely both contributed to the reduction of peptic ulcer disease, but the increase in reflux esophagitis remains to be fully explained.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III: Prevalence and clinical spectrum of gastroesophageal re-flux: A population-based study in Olmsted county, Minnesota. Gastroenterology 112:1448–1456, 1997

    Google Scholar 

  2. Revicki DA, Wood M, Maton PN, Sorensen S: The impact of gastroesophageal reflux disease on quality of life. Am J Med 104:252–258, 1998

    Google Scholar 

  3. Jensen DM: Economic and health aspects of peptic ulcer disease and H2-receptor antagonists. Am J Med 81:42–48, 1986

    Google Scholar 

  4. Wilhelmsen I, Berstad A: Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol 29:874–879, 1994.

    Google Scholar 

  5. Marshall, BJ: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273–275, 1983

    Google Scholar 

  6. Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease: Helicobacter pylori in peptic ulcer disease. JAMA 272:65–69, 1994

    Google Scholar 

  7. International Agency for Research on Cancer: Schistosomes, liver flukes and Helicobacter pylori. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Monograph, Vol 61. Lyon, IARC, 1994, pp. 177–241

    Google Scholar 

  8. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M: Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 115:642–648, 1998

    Google Scholar 

  9. Eslick GD, Lim L L-Y, Byles JE, Xia H H-X, Talley NJ: Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94:2373–1379, 1999

    Google Scholar 

  10. Xia H H-X, Talley NJ: Prospects for improved therapy for Helicobacter pylori infection. Exp Opin Invest Drugs 5:959–976, 1996

    Google Scholar 

  11. Lam SK, Talley NJ: Helicobacter pylori consensus. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 13:1–12, 1998

    Google Scholar 

  12. Xia HH-X, Talley NJ: Helicobacter pylori eradication in patients with non-ulcer dyspepsia. Drugs 58:785–792, 1999

    Google Scholar 

  13. Xia HH-X, Kalantar J, Talley NJ, Ma Wyatt J, Adams S, Cheung K: Antral-type mucosa in the gastric incisura (antralization)– a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol 95:114–121, 2000

    Google Scholar 

  14. Borody TJ, Andrews P, Jankiewicz E, et al: Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori. Am J Gastroenterol 88:1266–1268, 1993

    Google Scholar 

  15. Forbes GM, Warren JR, Glaser ME, Cullen DJ, Marshall BJ, Collins BJ: Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 112:670–673, 1996

    Google Scholar 

  16. Tucci A, Poli L, Tosetti C, Biasco G, et al: Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 93:1425–1431, 1998

    Google Scholar 

  17. Annibale B, Rosaria Aprile M, S'Ambra G, Caruana P, Bordi C, Delle Fave G: Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 14:625–634, 2000

    Google Scholar 

  18. Xia HH-X, Talley NJ: Helicobacter pylori infection, atrophic gastritis and reflux esophagitis: An unexplored triangle. Am J Gastroenterol 93:394–400, 1998

    Google Scholar 

  19. O'Connor HJ: Helicobacter pylori and reflux gastro-oesophageal disease–clinical implications and management. Aliment Pharmacol Ther 13:117–1127, 1999

    Google Scholar 

  20. Fallone CA, Barkun AN, Friedman G, et al: Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 95:914–920, 2000

    Google Scholar 

  21. Hamada H, Haruma K, Mihara M, et al: High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: Impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 14:729–735, 2000

    Google Scholar 

  22. Haruma K, Hamada H, Mihara M, et al: Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: Case-control study in Japan. Helicobacter 5:24–29, 2000

    Google Scholar 

  23. Wu JCY, Sung JJ, Ng EKW, et al: Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: A study from the East. Am J Gastroenterol 94:1790–1794, 1999

    Google Scholar 

  24. Metz DC, Kroser JA: Helicobacter pylori and gastroesophageal reflux disease. Gastroenterol Clin North Am 28:871–885, 1999

    Google Scholar 

  25. Talley NJ, Janssens J, Lauritsen K, et al: No increase of reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial. Gastroenterology 114:A306, 1998 (abstract)

    Google Scholar 

  26. Vakil N, Hahn B, McSorley D: Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment Pharmacol Ther 14:45–51, 2000

    Google Scholar 

  27. Bytzer P, Havelund T, Moller Hansen J: Interobserver variation in the endoscopic diagnosis of reflux esophagitis. Scand J Gastroenterol 28:119–125, 1993

    Google Scholar 

  28. Armstrong D, Bennett JR, Blum AL, et al: The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology 111:85–92, 1996

    Google Scholar 

  29. Dixon MF, Genta RM, Yardley JH, Correa P, the participants in the International Workshop on the Histopathology of Gastritis, Houston 1994: Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 20:1161–1181, 1996

    Google Scholar 

  30. Marshall BJ, Warren JR, Francis GJ, Langton SR, Goodwin CS, Blincow ED: Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol 82:200–210, 1987

    Google Scholar 

  31. Kalantar J, Xia HH-X, Ma Wyatt J, Rose D, Talley NJ: Determination of optimal biopsy sites for detection of H. pylori in patients treated or not treated with antibiotic and antisecretory drugs. Gastroenterology 112:A165, 1997, (abstract)

    Google Scholar 

  32. Xia HH-X, Kalantar JS, Ma Wyatt J, et al: High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection. Diag Microbiol Infect Dis 36:69–74, 2000

    Google Scholar 

  33. Xia HH-X, Kalantar JS, Mitchell HM, Talley NJ: Can Helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther 15:615–624, 2000

    Google Scholar 

  34. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1315, 1984

    Google Scholar 

  35. Marshall BJ, McGechie DB, Rogers PA, Glancy RJ: Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 142:439–443, 1985

    Google Scholar 

  36. Lambert JR, Dunn KL, Eaves ER, Korman MG, Hansky J, Pinkard KJ: Pylori CLO in the human stomach. Med J Aust 143:174, 1985 (letter)

    Google Scholar 

  37. McManus P, Henry DA, Birkett DJ: Recent changes in the profile of prescription NSAID use in Australia. Med J Aust 172:188, 2000 (letter)

    Google Scholar 

  38. Henry A, Batey RG: Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment? Aust NZ J Med 28:345, 1998 (letter)

    Google Scholar 

  39. Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S: Short segment Barrett' oesophagus: Prevalence, diagnosis and associations. Gut 40:710–715, 1997

    Google Scholar 

  40. Nandurkar S, Talley NJ: Barrett' oesophagus: The long and the short of it. Am J Gastroenterol 94:30–40, 1999

    Google Scholar 

  41. Xia HH-X, Talley NJ: Natural acquisition and spontaneous elimination of Helicobacter pylori infection. Am J Gastroenterol 92:1780–1787, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong

    Harry Hua-Xiang Xia

  2. Department of Medicine, The University of Sydney, Nepean Hospital, Penrith, NSW, Australia

    Nghi Phung, Emin Altiparmak, Alexis Berry, Melanie Matheson & Nicholas J. Talley

Authors
  1. Harry Hua-Xiang Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nghi Phung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emin Altiparmak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexis Berry
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Melanie Matheson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nicholas J. Talley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xia, H.HX., Phung, N., Altiparmak, E. et al. Reduction of Peptic Ulcer Disease and Helicobacter pylori Infection but Increase of Reflux Esophagitis in Western Sydney Between 1990 and 1998. Dig Dis Sci 46, 2716–2723 (2001). https://doi.org/10.1023/A:1012731614075

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012731614075

Search

Navigation